רופילק 300

Quốc gia: Israel

Ngôn ngữ: Tiếng Do Thái

Nguồn: Ministry of Health

Thành phần hoạt chất:

ANTI-D IMMUNOGLOBULINS

Sẵn có từ:

CSL BEHRING LTD., ISRAEL

Mã ATC:

J06BB01

Dạng dược phẩm:

תמיסה להזרקה

Thành phần:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Tuyến hành chính:

תוך-שרירי, תוך-ורידי

Loại thuốc theo toa:

מרשם נדרש

Sản xuất bởi:

CSL BEHRING AG, SWITZERLAND

Nhóm trị liệu:

ANTI-D (RH) IMMUNOGLOBULIN

Khu trị liệu:

ANTI-D (RH) IMMUNOGLOBULIN

Chỉ dẫn điều trị:

Prophylaxis of Rh (D) immunisation in Rh (D)-negative women: Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known. Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy. Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child. Complications of pregnancy: Interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Ngày ủy quyền:

2023-02-28